5 Results for "

ALDH1A1-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ALDH1A1-IN-2" in MCE Product Catalog:

Cat. No.: HY-126003
CAS No.: 2231081-18-6
Purity:  99.31%
Research Areas:  

Cancer

ALDH1A1-IN-2 (compound 297) is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity .
loading...
    loading...
Cat. No.: HY-146682
CAS No.: 2408477-54-1
Purity:  99.61%
Research Areas:  

Cancer

KS100 is a potent ALDH inhibitor with IC50s of 230, 1542, 193 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS100 shows antiproliferative and anticancer effects with low low toxic. KS100 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS10600 induces apoptosis and cell cycle arrest at the G2/M phase .
loading...
    loading...
Cat. No.: HY-146683
CAS No.: 2408477-50-7
Purity:  99.31%
Research Areas:  

Cancer

KS106 is a potent ALDH inhibitor with IC50s of 334, 2137, 360 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS106 induces apoptosis and cell cycle arrest at the G2/M phase .
loading...
    loading...
Cat. No.: HY-134917
CAS No.: 499997-25-0
Research Areas:  

Metabolic Disease Cancer

Aldi-2 is a potent and specific covalent inhibitor of aldehyde dehydrogenases (ALDHs) with IC50s of 2.5, 6.4 and 1.9 μM against ALDH1A1, ALDH2 and ALDH3A1, respectively. Aldi-2 can be utilized in cancer research .
loading...
    loading...
Cat. No.: HY-187170
CAS No.: 3038211-56-9
BM-51 is a selective inhibitor of CYP4Z1, with a human IC50 value of 91.7 nM. BM-51 binds to amino acid residues of CYP4Z1, thereby inhibiting its enzymatic activity. BM-51 downregulates the protein expression of stem cell markers (ALDH1A1, SOX2, OCT3/4 and KLF4) in cancer cells, inhibits cancer cell migration and invasion, and exhibits low toxicity to normal cells/tissues. BM-51 suppresses tumor initiation capacity and enhances the chemotherapeutic efficacy of Doxorubicin (HY-15142A). BM-51 can be used in breast cancer-related research .
loading...
    loading...